litlas
ログインアカウント作成

Toshio Miyata

1992–2025 年に発表

124
論文数
18,510
被引用数
88
h 指数
121
i10 指数

被引用数

Toshio Miyata の年別被引用数1993 年: 被引用 10 件1994 年: 被引用 31 件1995 年: 被引用 67 件1996 年: 被引用 56 件1997 年: 被引用 84 件1998 年: 被引用 89 件1999 年: 被引用 144 件2000 年: 被引用 200 件2001 年: 被引用 190 件2002 年: 被引用 162 件2003 年: 被引用 211 件2004 年: 被引用 184 件2005 年: 被引用 205 件2006 年: 被引用 183 件2007 年: 被引用 167 件2008 年: 被引用 185 件2009 年: 被引用 164 件2010 年: 被引用 173 件2011 年: 被引用 161 件2012 年: 被引用 183 件2013 年: 被引用 188 件2014 年: 被引用 166 件2015 年: 被引用 139 件2016 年: 被引用 134 件2017 年: 被引用 145 件2018 年: 被引用 89 件2019 年: 被引用 384 件2020 年: 被引用 380 件2021 年: 被引用 382 件2022 年: 被引用 301 件2023 年: 被引用 207 件2024 年: 被引用 294 件2025 年: 被引用 162 件2026 年: 被引用 3 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,477 件、この内訳の 25.2%日本: 引用元論文 592 件、この内訳の 10.1%中国: 引用元論文 538 件、この内訳の 9.2%イギリス: 引用元論文 377 件、この内訳の 6.4%ドイツ: 引用元論文 340 件、この内訳の 5.8%イタリア: 引用元論文 267 件、この内訳の 4.6%フランス: 引用元論文 174 件、この内訳の 3%オーストラリア: 引用元論文 172 件、この内訳の 2.9%オランダ: 引用元論文 172 件、この内訳の 2.9%カナダ: 引用元論文 156 件、この内訳の 2.7%インド: 引用元論文 143 件、この内訳の 2.4%韓国: 引用元論文 113 件、この内訳の 1.9%
0%25.2%その他 22.9%

機関

分野

  • Medicine43.3%
  • Biochemistry, Genetics and Molecular Biology43%
  • Immunology and Microbiology6.8%
  • Neuroscience1.8%
  • Nursing1.2%
  • Agricultural and Biological Sciences0.8%
  • その他3.1%

トピック

  • Advanced Glycation End Products research9%
  • Chronic Kidney Disease and Diabetes3.1%
  • Natural Antidiabetic Agents Studies2.5%
  • Dialysis and Renal Disease Management2.1%
  • Cancer, Hypoxia, and Metabolism1.8%
  • Complement system in diseases1.8%
  • その他79.7%

共著者

全論文

検索で開く
  1. Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis

    著者: Hajime Uno, Brian Claggett, Lü Tian, Eisuke Inoue, Paul Gallo, Toshio Miyata, Deborah Schrag, Masahiro Takeuchi, Yoshiaki Uyama, Lihui Zhao, Hicham Skali, Scott D. Solomon, Susanna Jacobus, Michael Hughes, Milton Packer, L. J. Wei - Journal of Clinical Oncology 2014 被引用: 782

  2. PAI-1 Regulation of TGF-β1–induced Alveolar Type II Cell Senescence, SASP Secretion, and SASP-mediated Activation of Alveolar Macrophages

    著者: Tapasi Rana, Chunsun Jiang, Gang Liu, Toshio Miyata, Veena B. Antony, Victor J. Thannickal, Rui-Ming Liu - American Journal of Respiratory Cell and Molecular Biology 2019 被引用: 158

  3. Social Networks and Natural Resource Management : Uncovering the Social Fabric of Environmental Governance

    著者: Kôji Uchida, Masamichi Kanematsu, Kensuke Sakai, Tsukasa Matsuda, Nobutaka Hattori, Yoshikuni Mizuno, Daisuke Suzuki, Toshio Miyata, Noriko Noguchi, Etsuo Niki, Toshihiko Osawa - Medical Entomology and Zoology 1998 被引用: 631

  4. A null mutation in SERPINE1 protects against biological aging in humans

    著者: Sadiya S. Khan, Sanjiv J. Shah, Ekaterina Klyachko, Abigail S. Baldridge, Mesut Eren, Aaron T. Place, Abraham Aviv, Eli Puterman, Donald M. Lloyd‐Jones, Meadow Heiman, Toshio Miyata, Sweta Gupta, Amy D. Shapiro, Douglas E. Vaughan - Science Advances 2017 被引用: 155

  5. PAI-1–regulated extracellular proteolysis governs senescence and survival in Klotho mice

    著者: Mesut Eren, Amanda E. Boe, Sheila B. Murphy, Aaron T. Place, Varun Nagpal, Luisa Morales‐Nebreda, Daniela Urich, Susan E. Quaggin, G. R. Scott Budinger, Gökhan M. Mutlu, Toshio Miyata, Douglas E. Vaughan - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 被引用: 175

  6. Role of PAI-1 in hepatic steatosis and dyslipidemia

    著者: Joshua A. Levine, Carlota Oleaga, Mesut Eren, Ansel P. Amaral, Meng Shang, Elizabeth Lux, Sadiya S. Khan, Sanjiv J. Shah, Yasuhiro Omura, Nathalie Pamir, Joshua Hay, Grant D. Barish, Toshio Miyata, Hagai Tavori, Sergio Fazio, Douglas E. Vaughan - Scientific Reports 2021 被引用: 109

  7. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria

    著者: Junji Takeda, Toshio Miyata, Kazuyoshi Kawagoe, Yoshiyasu Iida, Yuichi Endo, Teizo Fujita, Minoru Takahashi, Teruo Kitani, Taroh Kinoshita - Cell 1993 被引用: 1,049

  8. Plasminogen Activator Inhibitor-1 Antagonist TM5441 Attenuates N ω -Nitro- l -Arginine Methyl Ester–Induced Hypertension and Vascular Senescence

    著者: Amanda E. Boe, Mesut Eren, Sheila B. Murphy, Christine Kamide, Atsuhiko Ichimura, David Terry, Danielle McAnally, Layton H. Smith, Toshio Miyata, Douglas E. Vaughan - Circulation 2013 被引用: 132

  9. Increase in the advanced glycation end product pentosidine in Bruch's membrane with age.

    著者: James T. Handa, Nicole Verzijl, H Matsunaga, Amy E. Aotaki-Keen, Gerard A. Lutty, J.M. te Koppele, Toshio Miyata, L. M. Hjelmeland - 1999 被引用: 238

  10. Erythropoietin Synthesis in Renal Myofibroblasts Is Restored by Activation of Hypoxia Signaling

    著者: Tomokazu Souma, Masahiro Nezu, Daisuke Nakano, Shun Yamazaki, Ikuo Hirano, Hiroki Sekine, Takashi Dan, Kotaro Takeda, Guo‐Hua Fong, Akira Nishiyama, Sadayoshi Ito, Toshio Miyata, Masayuki Yamamoto, Norio Suzuki - Journal of the American Society of Nephrology 2015 被引用: 159

  11. Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology

    著者: Andre Berner, Olaf Brouwers, R. Pringle, Ingeborg Klaassen, Liza Colhoun, C.M. McVicar, Simon Brockbank, Jim Curry, Toshio Miyata, M. Brownlee, Reinier O. Schlingemann, Casper G. Schalkwijk, Alan W. Stitt - Diabetologia 2011 被引用: 151

  12. Plasminogen activator inhibitor-1 promotes immune evasion in tumors by facilitating the expression of programmed cell death-ligand 1

    著者: Abd Aziz Ibrahim, Taku Fujimura, Tomoko Uno, Tomoya Terada, Ken‐ichi Hirano, Hiroyuki Hosokawa, Akio Ohta, Toshio Miyata, Kiyoshi Ando, Takashi Yahata - Frontiers in Immunology 2024 被引用: 39

  13. A phase II multicentre study of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab for treating anti-programmed cell death 1 antibody-refractory malignant melanoma: TM5614-MM trial

    著者: Taku Fujimura, Koji Yoshino, Hiroshi Kato, Satoshi Fukushima, Shoichiro Ishizuki, Atsushi Otsuka, Shigeto Matsushita, Ryo Amagai, Yusuke Muto, Emi Yamazaki, Yumi Kambayashi, Takashi Yahata, Toshio Miyata, Yasuhiro Fujisawa, Yoshihide Asano - British Journal of Dermatology 2024 被引用: 26

  14. Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG‐A gene.

    著者: Monica Bessler, Philip J. Mason, Peter Hillmen, Toshio Miyata, Norio Yamada, Junji Takeda, Lucio Luzzatto, Taroh Kinoshita - The EMBO Journal 1994 被引用: 403

  15. Overexpression of Glyoxalase-I Reduces Hyperglycemia-induced Levels of Advanced Glycation End Products and Oxidative Stress in Diabetic Rats

    著者: Olaf Brouwers, Petra Niessen, Isabel Ferreira, Toshio Miyata, P Scheffer, Tom Teerlink, Patrick Schrauwen, Michael Brownlee, Coen D.A. Stehouwer, Casper G. Schalkwijk - Journal of Biological Chemistry 2010 被引用: 227

  16. Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease

    著者: Rika Dei, Akinori Takeda, Hisayoshi Niwa, Mei Li, Yuji Nakagomi, Masaki Watanabe, Toshiaki Inagaki, Yukihiko Washimi, Yoshinari Yasuda, Katsunori Horie, Toshio Miyata, Gen Sobue - Acta Neuropathologica 2002 被引用: 181

  17. A small molecule inhibitor of PAI-1 protects against doxorubicin-induced cellular senescence

    著者: Asish K. Ghosh, Rahul Rai, Kitae E. Park, Mesut Eren, Toshio Miyata, Lisa D. Wilsbacher, Douglas E. Vaughan - Oncotarget 2016 被引用: 92

  18. High-sucrose diets contribute to brain angiopathy with impaired glucose uptake and psychosis-related higher brain dysfunctions in mice

    著者: Shinobu Hirai, Hideki Miwa, Tomoko Tanaka, Kazuya Toriumi, Yasuto Kunii, Hiroko Shimbo, Takuya Sakamoto, Mizuki Hino, Ryuta Izumi, Atsuko Nagaoka, Hirooki Yabe, Tomoya Nakamachi, Seiji Shioda, Takashi Dan, Toshio Miyata, Yasumasa Nishito, Kazuhiro Suzuki, Mitsuhiro Miyashita, Toshifumi Tomoda, Takatoshi Hikida, Junjiro Horiuchi, Masanari Itokawa, Makoto Arai, Haruo Okado - Science Advances 2021 被引用: 41

  19. Methylglyoxal Is a Predictor in Type 2 Diabetic Patients of Intima-Media Thickening and Elevation of Blood Pressure

    著者: Susumu Ogawa, Keisuke Nakayama, Masaaki Nakayama, Takefumi Mori, Masato Matsushima, Masashi Okamura, Miho Senda, Kazuhiro Nako, Toshio Miyata, Sadayoshi Ito - Hypertension 2010 被引用: 108

  20. PAI-1 contributes to homocysteine-induced cellular senescence

    著者: Tianjiao Sun, Asish K. Ghosh, Mesut Eren, Toshio Miyata, Douglas E. Vaughan - Cellular Signalling 2019 被引用: 48

  21. Inhibition of plasminogen activator inhibitor-1 attenuates against intestinal fibrosis in mice

    著者: Jin Imai, Takashi Yahata, Hitoshi Ichikawa, Abd Aziz Ibrahim, Masaki Yazawa, Hideaki Sumiyoshi, Yutaka Inagaki, Masashi Matsushima, Takayoshi Suzuki, Tetsuya Mine, Kiyoshi Ando, Toshio Miyata, Katsuto Hozumi - Intestinal Research 2020 被引用: 26

  22. Deep molecular response in patients with chronic phase chronic myeloid leukemia treated with the plasminogen activator inhibitor‐1 inhibitor TM5614 combined with a tyrosine kinase inhibitor

    著者: Naoto Takahashi, Yoshihiro Kameoka, Makoto Onizuka, Yasushi Onishi, Fumiaki Takahashi, Takashi Dan, Toshio Miyata, Kiyoshi Ando, Hideo Harigae - Cancer Medicine 2022 被引用: 24

  23. Early- and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics

    著者: Casper G. Schalkwijk, Toshio Miyata - Amino Acids 2010 被引用: 130

  24. A Novel Inhibitor of Plasminogen Activator Inhibitor-1 Provides Antithrombotic Benefits Devoid of Bleeding Effect in Nonhuman Primates

    著者: Yuko Izuhara, Nagahisa Yamaoka, Hidehiko Kodama, Takashi Dan, Shunya Takizawa, N. Hirayama, Kanji Meguro, Charles van Ypersele de Strihou, Toshio Miyata - Journal of Cerebral Blood Flow & Metabolism 2010 被引用: 109